Patients protest against possible withdrawal of rare liver disease medicine

The European Medicines Agency's human medicines committee has triggered outrage among patients by recommending

EURACTIV

R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the πŸ‡ͺπŸ‡Ί.

➑️ https://www.ema.europa.eu/en/news/first-gene-editing-therapy-treat-beta-thalassemia-and-severe-sickle-cell-disease

#CHMP #PublicHealth

πŸ¦πŸ”—: https://nitter.cz/EMA_News/status/1735660082413592605#m

[2023-12-15 13:56 UTC]

First gene editing therapy to treat beta thalassemia and severe sickle cell disease | European Medicines Agency

Today’s authorisation by the European Medicines Agency is an important step ahead of winter so that people can increase their protection against RSV.
I encourage Member States to make it available to citizens quickly, especially the most vulnerable.
<div class="rsshub-quote">
EU Medicines Agency:β€‚πŸ“’EMA's human medicines committee recommended 14 new medicines for approval in the πŸ‡ͺπŸ‡Ί, including:
β˜‘οΈ1 vaccine to protect against Respiratory Syncytial Virus #RSV
β˜‘οΈ7 medicines for #cancer
β˜‘οΈ1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10
</div>

πŸ¦πŸ”—: https://n.respublicae.eu/SKyriakidesEU/status/1682382166439673857

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 17-20 July 2023 - European Medicines Agency

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 17-20 July 2023

European Medicines Agency

πŸ“’EMA's human medicines committee recommended 14 new medicines for approval in the πŸ‡ͺπŸ‡Ί, including:
β˜‘οΈ1 vaccine to protect against Respiratory Syncytial Virus #RSV
β˜‘οΈ7 medicines for #cancer
β˜‘οΈ1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1682364425775325184

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 17-20 July 2023 - European Medicines Agency

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 17-20 July 2023

European Medicines Agency

The agenda of EMA's human #medicines committee #CHMP is now published.
Find out what medicines will be discussed this month πŸ’ŠπŸ’‰
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-17-20-july-2023_en.pdf

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1680843262297341956

RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. πŸ’ŠπŸ’‰
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1670740308567416837

RT EU Medicines Agency
πŸ“’EMA's human medicines committee, the #CHMP, recommended 2⃣ new medicines for approval in the πŸ‡ͺπŸ‡Ί, including:
β˜‘οΈ one medicine for the prophylaxis of #migraine
β˜‘οΈ one medicine for the treatment of chronic #KidneyDisease
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2023
#PublicHealth https://t.co/MmoBuogHs2

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1672221581534195712

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 19-22 June 2023 - European Medicines Agency

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 19-22 June 2023

European Medicines Agency

πŸ“’EMA's human medicines committee, the #CHMP, recommended 2 new medicines πŸ’Šfor approval in the πŸ‡ͺπŸ‡Ί, including:
β˜‘οΈ one medicine to diagnose prostate #cancer
β˜‘οΈ one medicine for the treatment of #epilepsy
#publichealth πŸ‘‡https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-may-2023

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1662075982381998081

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 22-25 May 2023 - European Medicines Agency

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 22-25 May 2023

European Medicines Agency

The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month πŸ’ŠπŸ’‰ πŸ‘‡
The committee highlights will be released on Friday.

https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-22-25-may-2023_en.pdf

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1660574487530598400

πŸ“’EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the πŸ‡ͺπŸ‡Ί, including:
β˜‘οΈ one vaccine for Respiratory Syncytial Virus #RSV
β˜‘οΈ three medicines for #cancer
β˜‘οΈ one medicine for a rare disease #Pompe

#publichealth

πŸ‘‰ https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-24-26-april-2023

πŸ¦πŸ”—: https://n.respublicae.eu/EMA_News/status/1651265157538930689

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 24 - 26 April 2023 European Medicines Agency

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP) 24 - 26 April 2023

European Medicines Agency